{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:26Z","timestamp":1792787306605,"version":"4.5.0"},"reference-count":51,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203331"],"award-info":[{"award-number":["NIHR203331"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health and Care Research Exeter Biomedical Research Centre","award":["NIHR203320"],"award-info":[{"award-number":["NIHR203320"]}],"id":[{"id":"https:\/\/ror.org\/0187kwz08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Yorkshire Cancer Research","award":["L394"],"award-info":[{"award-number":["L394"]}],"id":[{"id":"https:\/\/ror.org\/02cddnn97","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2026,8,5]]},"DOI":"10.1136\/jmg-2026-111623","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:20:29Z","timestamp":1791998429000},"page":"jmg-2026-111623","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["UK consensus recommendations for onward testing for Lynch syndrome in patients with deficient mismatch repair (dMMR) non-colorectal\/non-endometrial cancers"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-9216","authenticated-orcid":false,"given":"Terri Patricia","family":"McVeigh","sequence":"first","affiliation":[{"name":"Royal Marsden Hospital NHS Trust, London, UK"},{"name":"The Institute of Cancer Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Armstrong","sequence":"additional","affiliation":[{"name":"East of England Genomic Medicine Service Alliance, Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Burn","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gallon","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University, Newcastle, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hanson","sequence":"additional","affiliation":[{"name":"Peninsula Regional Genetics Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, England, UK"},{"name":"Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Lalloo","sequence":"additional","affiliation":[{"name":"North West Genomic Medicine Service Alliance, Manchester Centre for Genomic Medicine, Manchester, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8626-188X","authenticated-orcid":false,"given":"Andrew","family":"Latchford","sequence":"additional","affiliation":[{"name":"St Mark\u2019s the National Bowel Hospital and Academic Institute, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Snape","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"West","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Leeds, Leeds, UK"},{"name":"Department of Histopathology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J","family":"Monahan","sequence":"additional","affiliation":[{"name":"St Mark\u2019s the National Bowel Hospital and Academic Institute, London, England, UK"},{"name":"Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2026101410201624000_jmg-2026-111623v1.1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41431-024-01708-6","article-title":"ERN GENTURIS guidelines on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management","volume":"32","author":"Colas","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"2026101410201624000_jmg-2026-111623v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-021-00694-3"},{"key":"2026101410201624000_jmg-2026-111623v1.3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/neuonc\/noad008","article-title":"EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection","volume":"25","author":"Capper","year":"2023","journal-title":"Neuro Oncol"},{"key":"2026101410201624000_jmg-2026-111623v1.4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.7020"},{"key":"2026101410201624000_jmg-2026-111623v1.5","unstructured":"NICE . NICE Guidance DG27: Molecular testing strategies for Lynch syndrome in people with colorectal cancer. 2017."},{"key":"2026101410201624000_jmg-2026-111623v1.6","unstructured":"NICE . NICE Guidance DG42: Testing strategies for Lynch syndrome in people with endometrial cancer. 2020."},{"key":"2026101410201624000_jmg-2026-111623v1.7","unstructured":"National genomic test directory . Rare and inherited disease eligibility criteria. V8.1, 2025. Available: https:\/\/www.england.nhs.uk\/publication\/national-genomic-test-directories"},{"key":"2026101410201624000_jmg-2026-111623v1.8","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-009-9302-4"},{"key":"2026101410201624000_jmg-2026-111623v1.9","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3181bb6bdc"},{"key":"2026101410201624000_jmg-2026-111623v1.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-013-9671-6"},{"key":"2026101410201624000_jmg-2026-111623v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70510-X"},{"key":"2026101410201624000_jmg-2026-111623v1.12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh034"},{"key":"2026101410201624000_jmg-2026-111623v1.13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S1470-2045(23)00595-8","article-title":"Universal testing of cutaneous sebaceous carcinoma: a missed opportunity in Lynch syndrome detection","volume":"25","author":"Rajan","year":"2024","journal-title":"Lancet Oncol"},{"key":"2026101410201624000_jmg-2026-111623v1.14","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1001\/jamaoncol.2020.4515","article-title":"Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial","volume":"6","author":"Oaknin","year":"2020","journal-title":"JAMA Oncol"},{"key":"2026101410201624000_jmg-2026-111623v1.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596"},{"key":"2026101410201624000_jmg-2026-111623v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30422-9"},{"key":"2026101410201624000_jmg-2026-111623v1.17","unstructured":"NHSEngland . NHS Genomic Medicine Service guidance to support demand management of genomic tests. 2025."},{"key":"2026101410201624000_jmg-2026-111623v1.18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/path.5422","article-title":"Molecular pathology of Lynch syndrome","volume":"250","author":"Cerretelli","year":"2020","journal-title":"J Pathol"},{"key":"2026101410201624000_jmg-2026-111623v1.19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1324"},{"key":"2026101410201624000_jmg-2026-111623v1.20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004485","article-title":"Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer","volume":"10","author":"Chakrabarti","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026101410201624000_jmg-2026-111623v1.21","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-025-03980-x","article-title":"Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacy","volume":"74","author":"Landre","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"2026101410201624000_jmg-2026-111623v1.22","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2024-109900"},{"key":"2026101410201624000_jmg-2026-111623v1.23","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2024-109886"},{"key":"2026101410201624000_jmg-2026-111623v1.24","unstructured":"National Institute for Health and Care Excellence . Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. NICE guideline; 2013. Available: https:\/\/www.nice.org.uk\/guidance\/cg164"},{"key":"2026101410201624000_jmg-2026-111623v1.25","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9258396"},{"key":"2026101410201624000_jmg-2026-111623v1.26","doi-asserted-by":"crossref","unstructured":"Bonneville R , Krook MA , Kautto EA , et al . Landscape of Microsatellite Instability Across 39 Cancer Types. JCO Precis Oncol 2017. doi:10.1200\/PO.17.00073","DOI":"10.1200\/PO.17.00073"},{"key":"2026101410201624000_jmg-2026-111623v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23319-1"},{"key":"2026101410201624000_jmg-2026-111623v1.28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00283"},{"key":"2026101410201624000_jmg-2026-111623v1.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130409","article-title":"Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer","volume":"10","author":"Shigeyasu","year":"2015","journal-title":"PLoS One"},{"key":"2026101410201624000_jmg-2026-111623v1.30","first-page":"159","article-title":"hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability","volume":"59","author":"Leung","year":"1999","journal-title":"Cancer Res"},{"key":"2026101410201624000_jmg-2026-111623v1.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2077-8","article-title":"Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach","volume":"16","author":"Kupcinskaite-Noreikiene","year":"2016","journal-title":"BMC Cancer"},{"key":"2026101410201624000_jmg-2026-111623v1.32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0713"},{"key":"2026101410201624000_jmg-2026-111623v1.33","first-page":"3455","article-title":"Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability","volume":"58","author":"Cunningham","year":"1998","journal-title":"Cancer Res"},{"key":"2026101410201624000_jmg-2026-111623v1.34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1012168","article-title":"Clinicopathological characteristics and loss of mismatch repair protein expression in Chinese upper tract urothelial carcinomas","volume":"12","author":"Shang","year":"2022","journal-title":"Front Oncol"},{"key":"2026101410201624000_jmg-2026-111623v1.35","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10147-024-02518-y","article-title":"Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome","volume":"29","author":"Ito","year":"2024","journal-title":"Int J Clin Oncol"},{"key":"2026101410201624000_jmg-2026-111623v1.36","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2020-107542"},{"key":"2026101410201624000_jmg-2026-111623v1.37","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32203"},{"key":"2026101410201624000_jmg-2026-111623v1.38","doi-asserted-by":"crossref","DOI":"10.1200\/PO.22.00525","article-title":"Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma","volume":"7","author":"Benusiglio","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"2026101410201624000_jmg-2026-111623v1.39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1470-2045(24)00640-5","article-title":"The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study","volume":"26","author":"Negm","year":"2025","journal-title":"Lancet Oncol"},{"key":"2026101410201624000_jmg-2026-111623v1.40","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-025-02846-x","article-title":"MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma","volume":"149","author":"Friker","year":"2025","journal-title":"Acta Neuropathol"},{"key":"2026101410201624000_jmg-2026-111623v1.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003263","article-title":"The proportion of endometrial tumours associated with Lynch syndrome (Petals): A prospective cross-sectional study","volume":"17","author":"Ryan","year":"2020","journal-title":"PLoS Med"},{"key":"2026101410201624000_jmg-2026-111623v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-024-01550-w"},{"key":"2026101410201624000_jmg-2026-111623v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.19"},{"key":"2026101410201624000_jmg-2026-111623v1.44","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2025-110947"},{"key":"2026101410201624000_jmg-2026-111623v1.45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10689-023-00337-0","article-title":"A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case report","volume":"22","author":"Walker","year":"2023","journal-title":"Fam Cancer"},{"key":"2026101410201624000_jmg-2026-111623v1.46","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-012-9568-9"},{"key":"2026101410201624000_jmg-2026-111623v1.47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ajmg.a.32620","article-title":"Somatic mosaicism in a patient with Lynch syndrome","volume":"149A","author":"Pastrello","year":"2009","journal-title":"Am J Med Genet A"},{"key":"2026101410201624000_jmg-2026-111623v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3424"},{"key":"2026101410201624000_jmg-2026-111623v1.49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030406","article-title":"How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies","volume":"13","author":"Gallon","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026101410201624000_jmg-2026-111623v1.50","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0061"},{"key":"2026101410201624000_jmg-2026-111623v1.51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41431-025-01913-x","article-title":"EMQN best practice guidelines for analysis and reporting of microsatellite instability in solid tumours","volume":"34","author":"Gallon","year":"2026","journal-title":"Eur J Hum Genet"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2026-111623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:20:34Z","timestamp":1791998434000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2026-111623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":51,"alternative-id":["10.1136\/jmg-2026-111623"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2026-111623","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]}}}